The orphan nuclear receptor NR4A1 regulates insulin-like 3 gene transcription in Leydig cells

Biology of Reproduction

Volumn 74, Issue 2, 2006, Pages 322-330

  Robert, Nicholas M ^a   Martin, Luc J ^a   Tremblay, Jacques J ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

Gene regulation; Growth factors; Leydig cells; Ovary; Testis

Indexed keywords

CELL NUCLEUS RECEPTOR; CYCLIC AMP; HORMONE; INSULIN LIKE 3; NUCLEAR RECEPTOR NUR77; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL SURVIVAL; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GENE; GENE EXPRESSION REGULATION; GENE INDUCTION; GENE LOCATION; GENE MAPPING; GERM CELL; GONAD; INSL3 GENE; LEYDIG CELL; LUTEAL CELL; MALE; MOUSE; NONHUMAN; OOCYTE MATURATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PROTEIN INTERACTION; REPRODUCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEX DIFFERENTIATION; THECA CELL; TISSUE SPECIFICITY; TRANSCRIPTION REGULATION;

ANIMALS; BASE SEQUENCE; BINDING SITES; CELL LINE; CONSERVED SEQUENCE; CYCLIC AMP; DNA-BINDING PROTEINS; HUMANS; INSULIN; LEYDIG CELLS; MALE; MICE; MICE, INBRED STRAINS; PROMOTER REGIONS (GENETICS); PROTEINS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, STEROID; RESPONSE ELEMENTS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

ANIMALIA;

EID: 31044450240     PISSN: 00063363     EISSN: None     Source Type: Journal    
DOI: 10.1095/biolreprod.105.044560     Document Type: Article

References (61)

1. Adham IM, Burkhardt E, Benahmed M, Engel W. Cloning of a cDNA for a novel insulin-like peptide of the testicular Leydig cells. J Biol Chem 1993; 268:26668-26672.
2. Pusch W, Balvers M, Ivell R. Molecular cloning and expression of the relaxin-like factor from the mouse lestis. Endocrinology 1996; 137:3009-3013.
3. Zimmermann S, Schottler P, Engel W, Adham IM. Mouse Leydig insulin-like (Ley I-L) gene: structure and expression during testis and ovary development. Mol Reprod Dev 1997; 47:30-38.
4. Balvers M, Spiess AN, Domagalski R, Hunt N, Kilic E, Mukhopadhyay AK, Hanks E, Charlton HM, Ivell R. Relaxin-like factor expression as a marker of differentiation in the mouse testis and ovary. Endocrinology 1998; 139:2960-2970.
5. O'Shaughnessy PJ, Willerton L, Baker PJ. Changes in Leydig cell gene expression during development in the mouse. Biol Reprod 2002; 66:966-975.
6. Paust HJ, Wessels J, Ivell R, Mukhopadhyay AK. The expression of the RLF/INSL3 gene is reduced in Leydig cells of the aging rat testis. Exp Gerontol 2002; 37:1461-1467.
7. Cattanach BM, Iddon CA, Charlton HM, Chiappa SA, Fink G. Gonadotrophin-releasing hormone deficiency in a mutant mouse with hypogonadism. Nature 1977; 269:338-340.
8. Mason AJ, Hayflick JS, Zoeller RT, Young WS III, Phillips HS, Nikolics K, Seeburg PH. A deletion truncating the gonadotropin-releasing hormone gene is responsible for hypogonadism in the hpg mouse. Science 1986; 234:1366-1371.
9. Kawamura K, Kumagai J, Sudo S, Chun SY, Pisarska M, Morita H, Toppari J, Fu P, Wade JD, Bathgate RA, Hsueh AJ. Paracrine regulation of mammalian oocyte maturation and male germ cell survival. Proc Natl Acad Sci U S A 2004; 101:7323-7328.
10. Hutson JM, Donahoe PK. The hormonal control of testicular descent. Endocr Rev 1986; 7:270-283.
11. Hutson JM. A biphasic model for the hormonal control of testiculur descent. Lancet 1985; 2:419-421.
12. Nef S, Parada LF. Cryptorchidism in mice mutant for Insl3. Nat Genet 1999; 22:295-299.
13. Zimmermann S, Steding G, Emmen JM, Brinkmann AO, Nayernia K, Holstein AF, Engel W, Adham IM. Targeted disruption of the Insl3 gene causes bilateral cryptorchidism. Mol Endocrinol 1999; 13:681-691.
14. Adham IM, Steding G, Thamm T, Bullesbach EE, Schwabe C, Paprotta I, Engel W. The overexpression of the insD in female mice causes descent of the ovaries. Mol Endocrinol 2002; 16:244-252.
15. Koskimies P, Suvanto M, Nokkala E, Huhtaniemi IT, McLuskey A, Themmen AP, Poutanen M. Female mice carrying a ubiquitin promoter-InsB transgene have descended ovaries and inguinal hernias but normal fertility. Mol Cell Endocrinol 2003; 206:159-166.
16. Burkhardt E, Adham IM, Brosig B, Gastmann A, Mattei MG, Engel W. Structural organization of the porcine and human genes coding for a Leydig cell-specific insulin-like peptide (LEY 1-L) and chromosomal localization of the human gene (INSL3). Genomics 1994; 20:13-19.
17. Spiess AN, Balvers M, Tena-Sempere M, Huhtaniemi I, Parry L, Ivell R. Structure and expression of the rat relaxin-like factor (RLF) gene. Mol Reprod Dev 1999; 54:319-325.
18. Truong A, Bogatcheva NV, Schelling C, Dolf G, Agoulnik AI. Isolation and expression analysis of the canine insulin-like factor 3 gene. Biol Reprod 2003; 69:1658-1664.
19. Koskimies P, Levallet J, Sipila P, Huhtaniemi I, Poutanen M. Murine relaxin-like factor promoter: functional characterization and regulation by transcription factors steroidogenic factor 1 and DAX-1. Endocrinology 2002; 143:909-919.
20. Zimmermann S, Schwarzler A, Buth S, Engel W, Adham IM. Transcription of the Leydig insulin-like gene is mediated by steroidogenic factor-1. Mol Endocrinol 1998; 12:706-713.
21. Jeyasuria P, Ikeda Y, Jamin SP, Zhao L, de Rooij DG, Themmen AP, Behringer RR, Parker KL. Cell-specific knockout of steroidogenic factor I reveals its essential roles in gonadal function. Mol Endocrinol 2004; 18:1610-1619.
22. Val P, Lefrancois-Martinez AM, Veyssiere G, Martinez A. SF-1 a key player in the development and differentiation of steroidogenic tissues. Nucl Recept 2003; 1:8.
23. 4 isomerase type 2 promoter is a novel target for the immediate early orphan nuclear receptor Nur77 in steroidogenic cells. Endocrinology 2005; 146:861-869.
24. Song KH, Park JI, Lee MO, Soh J, Lee K, Choi HS. LH induces orphan nuclear receptor Nur77 gene expression in testicular Leydig cells. Endocrinology 2001; 142:5116-5123.
25. Wilson TE, Fahrner TJ, Milbrandt J. The orphan receptors NGFI-B and steroidogenic factor 1 establish monomer binding as a third paradigm of nuclear receptor-DNA interaction. Mol Cell Biol 1993; 13:5794-5804.
26. Hong CY, Park JH, Ahn RS, Im SY, Choi HS, Soh J, Mellon SH, Lee K. Molecular mechanism of suppression of testicular steroidogenesis by proinflammatory cytokine tumor necrosis factor alpha. Mol Cell Biol 2004; 24:2593-2604.
27. Zhang P, Mellon SH. Multiple orphan nuclear receptors converge to regulate rat P450c17 gene transcription: novel mechanisms for orphan nuclear receptor action. Mol Endocrinol 1997; 11:891-904.
28. Tremblay JJ, Viger RS. Transcription factor GATA-4 enhances Mullerian inhibiting substance gene transcription through a direct interaction with the nuclear receptor SF-1. Mol Endocrinol 1999; 13:1388-1401.
29. Tremblay JJ, Viger RS. GATA factors differentially activate multiple gonadal promoters through conserved GATA regulatory elements. Endocrinology 2001; 142:977-986.
30. Philips A, Lesage S, Gingras R, Maira MH, Gauthier Y, Hugo P, Drouin J. Novel dimeric Nur77 signaling mechanism in endocrine and lymphoid cells. Mol Cell Biol 1997; 17:5946-5951.
31. Galarneau L, Pare JF, Allard D, Hamel D, Levesque L, Tugwood JD, Green S, Belanger L. The alpha 1-fetoprotein locus is activated by a nuclear receptor of the Drosophila FTZ-F1 family. Mol Cell Biol 1996; 16:3853-3865.
32. Paquis-Flucklinger V, Michiels JF, Vidal F, Alquier C, Pointis G, Bourdon V, Cuzin F, Rassoulzadegan M. Expression in transgenic mice of the large T antigen of polyomavirus induces Sertoli cell tumours and allows the establishment of differentiated cell lines. Oncogene 1993; 8:2087-2094.
33. Mather JP. Establishment and characterization of two distinct mouse testicular epithelial cell lines. Biol Reprod 1980; 23:243-252.
34. McGuinness MP, Linder CC, Morales CR, Heckert LL, Pikus J, Griswold MD. Relationship of a mouse Sertoli cell line (MSC-1) to normal Sertoli cells. Biol Reprod 1994; 51:116-124.
35. Ascoli M. Characterization of several clonal lines of cultured Leydig tumor cells: gonadotropin receptors and steroidogenic responses. Endocrinology 1981; 108:88-95.
36. Chomczynski P, Sacchi N, Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162:156-159.
37. Spencer VA, Sun JM, Li L, Davie JR. Chromatin immunoprecipitation: a tool for studying histone acetylation and transcription factor binding. Methods 2003; 31:67-75.
38. Small CL, Shima JE, Uzumcu M, Skinner MK, Griswold MD. Profiling gene expression during the differentiation and development of the murine embryonic gonad. Biol Reprod 2005; 72:492-501.
39. Park JI, Park HJ, Choi HS, Lee K, Lee WK, Chun SY. Gonadotropin regulation of NGFI-B messenger ribonucleic acid expression during ovarian follicle development in the ral. Endocrinology 2001; 142:3051-3059.
40. Wilson TE, Fahrner TJ, Johnston M, Milbrandt J. Identification of the DNA binding site for NGFI-B by genetic selection in yeast. Science 1991; 252:1296-1300.
41. Crawford PA, Sadovsky Y, Woodson K, Lee SL, Milbrandt J. Adrenocortical function and regulation of the steroid 21-hydroxylase gene in NGFI-B-deficient mice. Mol Cell Biol 1995; 15:4331-4336.
42. Cheng LE, Chan FK, Cado D, Winoto A. Functional redundancy of the Nur77 and Nor-1 orphan steroid receptors in T-cell apoptosis. EMBO J 1997; 16:1865-1875.
43. Park JI, Park HJ, Lee YI, Seo YM, Chun SY. Regulation of NGFI-B expression during the ovulatory process. Mol Cell Endocrinol 2003; 202:25-29.
44. Sadale-Ngatchou PI, Pouchnik DJ, Griswold MD. Follicle-stimulating hormone induced changes in gene expression of murine teslis. Mol Endocrinol 2004; 18:2805-2816.
45. Ascoli M, Fanelli F, Segaloff DL. The futropin/choriogonadotropin receptor, a 2002 perspective. Endocr Rev 2002; 23:141-174.
46. Bay K, Hartung S, Iveil R, Schumacher M, Jurgensen D, Jorgensen N, Holm M, Skakkebaek NE, Andersson AM. Insulin-like factor 3 serum levels in 135 normal men and 85 men with testicular disorders: relationship to the luteinizing hormone-testosterone axis. J Clin Endocrinol Metab 2005; 90:3410-3418.
47. Gill WB, Schumacher GF, Bibbo M, Straus FH, Schoenberg HW. Association of diethylstilbestrol exposure in utero with cryptorchidism, testicular hypoplasia and semen abnormalities. J Urol 1979; 122:36-39.
48. Stillman RJ. In utero exposure to diethylstilbestrol: adverse effects on the reproductive tract and reproductive performance and male and female offspring. Am J Obstet Gynecol 1982; 142:905-921.
49. Hadziselimovic F, Geneto R, Emmons LR. Elevated placental estradiol: a possible etiological factor of human cryptorchidism. J Urol 2000; 164:1694-1695.
50. Emmen JM, McLuskey A, Adham IM, Engel W, Grootegoed JA, Brinkmann AO. Hormonal control of gubernaculum development during testis descent: gubernaculum outgrowth in vitro requires both insulin-like factor and androgen. Endocrinology 2000; 141:4720-4727.
51. Grocock CA, Charlton HM, Pike MC. Role of the letal pituitary in cryplorchidism induced by exogenous maternal oestrogen during pregnancy in mice. J Reprod Fertil 1988; 83:295-300.
52. McLachlan JA, Newbold RR, Burow ME, Li SF. From malformations to molecular mechanisms in the male: three decades of research on endocrine disrupters. APMIS 2001; 109:263-272.
53. Nef S, Shipman T, Parada LF. A molecular basis for estrogen-induced cryptorchidism. Dev Biol 2000; 224:354-361.
54. Toppari J, Skakkebaek NE. Sexual differentiation and environmental endocrine disrupters. Baillieres Clin Endocrinol Metab 1998; 12:143-156.
55. Barlow NJ, Foster PM. Pathogenesis of male reproductive tract lesions from gestation through adulthood following in utero exposure to di(n-butyl) phthalate. Toxicol Pathol 2003; 31:397-410.
56. Gray LE Jr, Wolf C, Lambright C, Mann P, Price M, Cooper RL, Ostby J. Administration of potentially antiandrogenic pesticides (procymidone, linuron, iprodione, chlozolinate, p,p′-DDE, and ketoconazole) and toxic substances (dibutyl- and diethylhexyl phthalate. PCB 169, and ethane dimethane sulphonate) during sexual differentiation produces diverse profiles of reproductive malformations in the male rat. Toxicol Ind Health 1999; 15:94-118.
57. Mylchreest E, Wallace DG, Cattley RC, Foster PM. Dose-dependent alterations in androgen-regulated male reproductive development in rats exposed to di(n-bulyl) phthalate during late gestation. Toxicol Sci 2000; 55:143-151.
58. Mylchreesl E, Sar M, Cattley RC, Foster PM. Disruption of androgen-regulated male reproductive development by di(n-bulyl) phthalale during late gestation in rats is different from flutamide. Toxicol Appl Pharmacol 1999; 156:81-95.
59. Emmen JM, McLuskey A, Adham IM, Engel W, Verhoef-Post M, Themmen AP, Grootegoed JA, Brinkmann AO. Involvement of insulin-like factor 3 (Insl3) in diethylstilbestrol-induced cryptorchidism. Endocrinology 2000; 141:846-849.
60. Wilson VS, Lambright C, Furr J, Ostby J, Wood C, Held G, Gray LE Jr., Phthalate ester-induced gubernacular lesions are associated with reduced insl3 gene expression in the fetal rat testis. Toxicol Lett 2004; 146:207-215.
61. Liu K, Lehmann KP, Sar M, Young SS, Gaido KW. Gene expression profiling following in utero exposure to phthalate esters reveals new gene targets in the etiology of testicular dysgenesis. Biol Reprod 2005; 73:180-192.